Arrowstreet Capital, Limited Partnership Adma Biologics, Inc. Transaction History
Arrowstreet Capital, Limited Partnership
- $121 Billion
- Q3 2024
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 1,749,244 shares of ADMA stock, worth $31 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,749,244
Previous 665,058
163.02%
Holding current value
$31 Million
Previous $7.44 Million
370.3%
% of portfolio
0.03%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding ADMA
# of Institutions
319Shares Held
184MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$330 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$321 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$230 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$224 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$152 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.48B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...